Abivax SA (0RA9) Ratios
Abivax SA Ratios
GB:0RA9's free cash flow for Q2 2026 was $-52.10M. For the 2026 fiscal year, GB:0RA9's free cash flow was decreased by $-112.00K and operating cash flow was $-51.99M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Mar 24 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 8.75 | 1.84 | 4.08 | 0.94 | 2.37 |
| Quick Ratio | 8.75 | 1.84 | 4.08 | 0.70 | 2.24 |
| Cash Ratio | 8.20 | 1.55 | 3.60 | 0.52 | 1.93 |
| Solvency Ratio | -2.59 | -1.06 | -1.12 | -0.84 | -0.52 |
| Operating Cash Flow Ratio | -2.57 | -1.66 | -1.39 | -1.27 | -1.45 |
| Short-Term Operating Cash Flow Coverage | 0.00 | -3.60 | -9.50 | -2.22 | -4.54 |
| Net Current Asset Value | $ 422.11M | $ 6.03M | $ 154.92M | $ -23.28M | $ -6.88M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.05 | 0.47 | 0.17 | 0.53 | 0.48 |
| Debt-to-Equity Ratio | 0.07 | 2.40 | 0.28 | 5.45 | 2.06 |
| Debt-to-Capital Ratio | 0.07 | 0.71 | 0.22 | 0.84 | 0.67 |
| Long-Term Debt-to-Capital Ratio | 0.06 | 0.56 | 0.19 | 0.79 | 0.61 |
| Financial Leverage Ratio | 1.28 | 5.06 | 1.67 | 10.20 | 4.26 |
| Debt Service Coverage Ratio | -8.85 | -2.83 | -5.35 | -1.34 | -2.79 |
| Interest Coverage Ratio | -8.79 | -13.14 | -9.21 | -9.23 | -14.67 |
| Debt to Market Cap | 0.00 | 0.22 | 0.13 | 0.48 | 0.11 |
| Interest Debt Per Share | 0.87 | 1.77 | 1.61 | 2.42 | 3.69 |
| Net Debt to EBITDA | 1.94 | 0.28 | 1.47 | -0.23 | 0.17 |
| Profitability Margins | |||||
| Gross Profit Margin | 0.00% | 100.00% | 97.23% | 98.45% | -321.62% |
| EBIT Margin | 0.00% | -1563.95% | -2897.94% | -1173.90% | -114462.16% |
| EBITDA Margin | 0.00% | -1553.76% | -2882.64% | -1163.32% | -114040.54% |
| Operating Profit Margin | 0.00% | -1718.24% | -2756.46% | -1414.71% | -141045.95% |
| Pretax Profit Margin | 0.00% | -1694.71% | -3294.37% | -1423.00% | -123137.84% |
| Net Profit Margin | 0.00% | -1633.08% | -3197.14% | -1325.33% | -114735.14% |
| Continuous Operations Profit Margin | 0.00% | -1633.08% | -3197.14% | -1325.33% | -111775.68% |
| Net Income Per EBT | 100.84% | 96.36% | 97.05% | 93.14% | 93.18% |
| EBT Per EBIT | 132.99% | 98.63% | 119.51% | 100.59% | 87.30% |
| Return on Assets (ROA) | -57.52% | -85.88% | -45.17% | -82.81% | -38.47% |
| Return on Equity (ROE) | -73.84% | -434.26% | -75.37% | -844.90% | -163.70% |
| Return on Capital Employed (ROCE) | -48.08% | -164.98% | -49.56% | -296.20% | -66.19% |
| Return on Invested Capital (ROIC) | -47.96% | -114.42% | -46.19% | -116.30% | -53.18% |
| Return on Tangible Assets | -60.09% | -97.80% | -48.91% | -220.95% | -91.76% |
| Earnings Yield | -4.02% | -41.35% | -34.93% | -51.48% | -9.62% |
| Efficiency Ratios | |||||
| Receivables Turnover | 0.00 | 0.69 | 0.24 | 0.55 | 0.00 |
| Payables Turnover | 0.03 | 0.03 | 0.00 | 0.00 | 0.01 |
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.01 | 0.04 |
| Fixed Asset Turnover | 0.00 | 4.05 | 5.26 | 14.23 | 0.40 |
| Asset Turnover | 0.00 | 0.05 | 0.01 | 0.06 | 0.00 |
| Working Capital Turnover Ratio | 0.00 | 0.07 | 0.04 | 0.23 | 0.00 |
| Cash Conversion Cycle | -12785.90 | -14011.86 | 1508.58 | -16240.79 | 48201.12 |
| Days of Sales Outstanding | 0.00 | 529.74 | 1508.58 | 662.30 | 82263.11 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 0.00 | 62651.48 | 9358.97 |
| Days of Payables Outstanding | 12785.90 | 14541.60 | 0.00 | 79554.58 | 43420.96 |
| Operating Cycle | 0.00 | 529.74 | 1508.58 | 63313.78 | 91622.08 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | -2.33 | -2.44 | -2.26 | -3.43 | -2.95 |
| Free Cash Flow Per Share | -2.33 | -2.45 | -2.26 | -3.64 | -3.06 |
| Dividend Paid and CapEx Coverage Ratio | -1141.47 | -239.61 | -366.53 | -16.53 | -27.81 |
| Capital Expenditure Coverage Ratio | -1141.47 | -239.61 | -366.53 | -16.53 | -27.81 |
| Operating Cash Flow Coverage Ratio | -5.05 | -1.58 | -1.75 | -1.67 | -0.85 |
| Operating Cash Flow to Sales Ratio | 0.00 | -14.28 | -21.02 | -14.31 | -1233.97 |
| Free Cash Flow Yield | -1.94% | -36.30% | -23.03% | -58.94% | -10.72% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -24.93 | -2.42 | -2.86 | -1.94 | -10.39 |
| Price-to-Sales (P/S) Ratio | 0.00 | 39.49 | 91.52 | 25.75 | 11926.18 |
| Price-to-Book (P/B) Ratio | 18.39 | 10.50 | 2.16 | 16.41 | 17.02 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -51.60 | -2.75 | -4.34 | -1.70 | -9.33 |
| Price-to-Operating Cash Flow Ratio | -51.65 | -2.77 | -4.35 | -1.80 | -9.66 |
| Price-to-Earnings Growth (PEG) Ratio | -0.34 | 0.13 | -0.36 | -0.12 | -2.09 |
| Enterprise Value Multiple | -31.60 | -2.26 | -1.70 | -2.44 | -10.29 |
| Enterprise Value | 7.89B | 379.33M | 226.43M | 130.21M | 434.02M |
| EV to EBITDA | -31.60 | -2.26 | -1.70 | -2.44 | -10.29 |
| EV to Sales | 0.00 | 35.15 | 49.00 | 28.41 | 11730.26 |
| EV to Free Cash Flow | -48.61 | -2.45 | -2.32 | -1.87 | -9.18 |
| EV to Operating Cash Flow | -48.66 | -2.46 | -2.33 | -1.99 | -9.51 |
| Tangible Book Value Per Share | 6.19 | 0.25 | 3.97 | -2.30 | -2.29 |
| Shareholders’ Equity Per Share | 6.55 | 0.64 | 4.55 | 0.38 | 1.68 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | -0.01 | 0.04 | 0.03 | 0.07 | 0.09 |
| Revenue Per Share | 0.00 | 0.17 | 0.11 | 0.24 | 0.00 |
| Net Income Per Share | -4.83 | -2.80 | -3.43 | -3.18 | -2.75 |
| Tax Burden | 1.01 | 0.96 | 0.97 | 0.93 | 0.93 |
| Interest Burden | 1.33 | 1.08 | 1.14 | 1.21 | 1.08 |
| Research & Development to Revenue | 0.00 | 13.58 | 22.33 | 10.63 | 1275.73 |
| SG&A to Revenue | 0.00 | 3.60 | 6.08 | 1.63 | 150.78 |
| Stock-Based Compensation to Revenue | 0.00 | 1.87 | 1.77 | -0.25 | 22.38 |
| Income Quality | 0.48 | 0.87 | 0.66 | 0.94 | 1.10 |
Currency in EUR